argenx SE/€ARGX

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About argenx SE

Argenx SE is a biotechnology company primarily engaged in the development of antibody-based therapies for the treatment of severe autoimmune diseases and cancer. The company leverages its proprietary SIMPLE Antibody™ platform to create differentiated immunology solutions. One of its flagship products is efgartigimod, designed to target the neonatal Fc receptor (FcRn) to modulate antibody levels, which has gained significant attention in therapeutic areas such as neuromuscular disorders. Founded in 2008, Argenx is headquartered in Ghent, Belgium, and has expanded its operations globally. The company's strategic positioning lies in its ability to combine deep insights into disease biology with cutting-edge technology to create novel treatments. Sources: - Argenx Official Website: www.argenx.com - "Argenx - Company Profile and News," Bloomberg, www.bloomberg.com

Ticker

€ARGX

Primary listing

BSE

Employees

1,599

argenx SE Metrics

BasicAdvanced
€36B
36.69
€16.22
0.03
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €ARGX

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs